Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuetsu Fukushi

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Japanese Journal of Infectious Diseases|May 1, 2018
Low Seroprevalence of Severe Fever with Thrombocytopenia Syndrome Virus Antibodies in Individuals Living in an Endemic Area in JapanMutsuyo Gokuden, Shuetsu Fukushi, Masayuki Saijo, et al.
Plos One|October 27, 2018
Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administrationHideki Tani, Takashi Komeno, Aiko Fukuma, et al.
Plos Neglected Tropical Diseases|July 2, 2021
Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virusHirofumi Kato, Mutsuyo Takayama-Ito, Masaaki Satoh, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 14, 2018
Expression of a Recombinant Nucleocapsid Protein of Rift Valley Fever Virus in Vero Cells as an Immunofluorescence Antigen and Its Use for Serosurveillance in Traditional Cattle Herds in ZambiaNgonda Saasa, Masahiro Kajihara, George Dautu, et al.
Clinical and Vaccine Immunology : CVI|July 20, 2007
Development of recombinant nucleoprotein-based diagnostic systems for Lassa feverMasayuki Saijo, Marie-Claude Georges-Courbot, Philippe Marianneau, et al.
Japanese Journal of Infectious Diseases|May 1, 2022
Longitudinal Trends of Prevalence of Neutralizing Antibody against Human Cytomegalovirus over the Past 30 Years in Japanese WomenMiho Shibamura, Souichi Yamada, Tomoki Yoshikawa, et al.
Viruses|January 8, 2025
A Mutation in the Herpes Simplex Virus Type 1 (HSV-1) UL29 Gene is Associated with Anti-Herpesvirus Drugs' SusceptibilitySouichi Yamada, Shizuko Harada, Hikaru Fujii, et al.
Virology Journal|August 5, 2020
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexesMiho Shibamura, Tomoki Yoshikawa, Souichi Yamada, et al.
Ejhaem|June 19, 2024
Successful treatment of acyclovir-resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T-cell prolymphocytic leukemiaYuma Kawamura, Nako Uchibori, Tomoya Arakawa, et al.
Emerging Infectious Diseases|March 19, 2020
Prevalence of Antibodies to Crimean-Congo Hemorrhagic Fever Virus in Ruminants, Nigeria, 2015Daniel Oluwayelu, Babak Afrough, Adebowale Adebiyi, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Japanese Journal of Infectious Diseases|May 1, 2018
Low Seroprevalence of Severe Fever with Thrombocytopenia Syndrome Virus Antibodies in Individuals Living in an Endemic Area in JapanMutsuyo Gokuden, Shuetsu Fukushi, Masayuki Saijo, et al.
Plos One|October 27, 2018
Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administrationHideki Tani, Takashi Komeno, Aiko Fukuma, et al.
Plos Neglected Tropical Diseases|July 2, 2021
Favipiravir treatment prolongs the survival in a lethal mouse model intracerebrally inoculated with Jamestown Canyon virusHirofumi Kato, Mutsuyo Takayama-Ito, Masaaki Satoh, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 14, 2018
Expression of a Recombinant Nucleocapsid Protein of Rift Valley Fever Virus in Vero Cells as an Immunofluorescence Antigen and Its Use for Serosurveillance in Traditional Cattle Herds in ZambiaNgonda Saasa, Masahiro Kajihara, George Dautu, et al.
Clinical and Vaccine Immunology : CVI|July 20, 2007
Development of recombinant nucleoprotein-based diagnostic systems for Lassa feverMasayuki Saijo, Marie-Claude Georges-Courbot, Philippe Marianneau, et al.
Japanese Journal of Infectious Diseases|May 1, 2022
Longitudinal Trends of Prevalence of Neutralizing Antibody against Human Cytomegalovirus over the Past 30 Years in Japanese WomenMiho Shibamura, Souichi Yamada, Tomoki Yoshikawa, et al.
Viruses|January 8, 2025
A Mutation in the Herpes Simplex Virus Type 1 (HSV-1) UL29 Gene is Associated with Anti-Herpesvirus Drugs' SusceptibilitySouichi Yamada, Shizuko Harada, Hikaru Fujii, et al.
Virology Journal|August 5, 2020
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexesMiho Shibamura, Tomoki Yoshikawa, Souichi Yamada, et al.
Ejhaem|June 19, 2024
Successful treatment of acyclovir-resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T-cell prolymphocytic leukemiaYuma Kawamura, Nako Uchibori, Tomoya Arakawa, et al.
Emerging Infectious Diseases|March 19, 2020
Prevalence of Antibodies to Crimean-Congo Hemorrhagic Fever Virus in Ruminants, Nigeria, 2015Daniel Oluwayelu, Babak Afrough, Adebowale Adebiyi, et al.
Pageof 16